| scholarly article | Q13442814 |
| P50 | author | Carlos S Moreno | Q41853265 |
| P2093 | author name string | Daniel Metzger | |
| Birdal Bilir | |||
| Demetri D Spyropoulos | |||
| W David Martin | |||
| Adeboye O Osunkoya | |||
| Veronique Lefebvre | |||
| Soma Sannigrahi | |||
| W Guy Wiles | |||
| P2860 | cites work | Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells | Q24294207 |
| Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells | Q24317198 | ||
| P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 | ||
| Organogenesis relies on SoxC transcription factors for the survival of neural and mesenchymal progenitors | Q24629179 | ||
| Outcomes of localized prostate cancer following conservative management | Q24647380 | ||
| Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase | Q24682825 | ||
| Cancer statistics, 2015 | Q27860576 | ||
| Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators | Q28143448 | ||
| Stabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth | Q28187862 | ||
| Linking beta-catenin to androgen-signaling pathway | Q28215632 | ||
| PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer | Q28292541 | ||
| Comprehensive molecular characterization of urothelial bladder carcinoma | Q28306864 | ||
| Pten is essential for embryonic development and tumour suppression | Q28509238 | ||
| Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer | Q28590839 | ||
| The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity | Q29547693 | ||
| GenePattern 2.0 | Q29614171 | ||
| Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression | Q29615223 | ||
| Endogenous human microRNAs that suppress breast cancer metastasis | Q29617352 | ||
| The Sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathways | Q33597010 | ||
| Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing | Q33693912 | ||
| Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis | Q34043392 | ||
| Molecular genetics of prostate cancer: new prospects for old challenges | Q34127462 | ||
| Studies on Prostatic Cancer: I. The Effect of Castration, Of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate | Q34215208 | ||
| Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer | Q35134003 | ||
| PTEN: from pathology to biology | Q35208577 | ||
| Transcriptional control of early B cell development | Q35698401 | ||
| Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma | Q36497352 | ||
| SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia | Q36512597 | ||
| Tenets of PTEN tumor suppression | Q37154214 | ||
| Activation of the Wnt pathway through AR79, a GSK3β inhibitor, promotes prostate cancer growth in soft tissue and bone | Q37407566 | ||
| The role of SRY-related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: friend or foe? | Q38068040 | ||
| Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy | Q39093621 | ||
| Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming | Q39140073 | ||
| Syntenin-mediated regulation of Sox4 proteasomal degradation modulates transcriptional output | Q39460417 | ||
| Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN | Q39711051 | ||
| The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer | Q39893596 | ||
| Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells | Q40291759 | ||
| Akt participation in the Wnt signaling pathway through Dishevelled | Q40817549 | ||
| Activation of β-catenin signaling in androgen receptor-negative prostate cancer cells | Q40834731 | ||
| Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases | Q44521056 | ||
| Generation of mice harboring a Sox4 conditional null allele | Q80159032 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1112-1121 | |
| P577 | publication date | 2015-12-23 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | SOX4 Is Essential for Prostate Tumorigenesis Initiated by PTEN Ablation | |
| P478 | volume | 76 |
| Q38973005 | Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer |
| Q54974720 | Epigenetic Regulation in Prostate Cancer Progression. |
| Q37590870 | Histological and Pathological Assessment of miR-204 and SOX4 Levels in Gastric Cancer Patients. |
| Q90569453 | Identification of Hub Genes in Hepatocellular Carcinoma Related to Progression and Prognosis by Weighted Gene Co-Expression Network Analysis |
| Q57475174 | Identification of the Transcription Factor Relationships Associated with Androgen Deprivation Therapy Response and Metastatic Progression in Prostate Cancer |
| Q47295311 | Inflammatory cytokines stabilize SOXC transcription factors to mediate the transformation of fibroblast-like synoviocytes in arthritic disease |
| Q90307891 | LINC01133 inhibits breast cancer invasion and metastasis by negatively regulating SOX4 expression through EZH2 |
| Q49415848 | Long noncoding RNA lncBRM facilitates the proliferation, migration and invasion of ovarian cancer cells via upregulation of Sox4. |
| Q49986924 | MicroRNA-320 inhibits cell proliferation and invasion in breast cancer cells by targeting SOX4. |
| Q99544101 | MicroRNA-92a Inhibits the Cell Viability and Metastasis of Prostate Cancer by Targeting SOX4 |
| Q90020747 | Molecular determinants of response to high-dose androgen therapy in prostate cancer |
| Q100526071 | Molecular tracing of prostate cancer lethality |
| Q92410975 | Neural Transcription Factors in Disease Progression |
| Q47189377 | Promoter hypermethylation of SOX11 correlates with adverse clinicopathological features of human prostate cancer. |
| Q38719688 | Propofol Suppresses Esophageal Squamous Cell Carcinoma Cell Migration and Invasion by Down-Regulation of Sex-Determining Region Y-box 4 (SOX4) |
| Q37133681 | SOX4 Promotes Progression in OLP-Associated Squamous Cell Carcinoma |
| Q90325674 | SOX4 is activated by C-MYC in prostate cancer |
| Q50430901 | SOX4: Joining the Master Regulators of Epithelial-to-Mesenchymal Transition? |
| Q64233013 | SOX5 promotes breast cancer proliferation and invasion by transactivation of EZH2 |
| Q41431023 | STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4. |
| Q42150559 | Secreted heat shock protein 90 promotes prostate cancer stem cell heterogeneity |
| Q37688454 | Subpathway-LNCE: Identify dysfunctional subpathways competitively regulated by lncRNAs through integrating lncRNA-mRNA expression profile and pathway topologies |
| Q93015985 | The SOX4/miR-17-92/RB1 Axis Promotes Prostate Cancer Progression |
| Q88506869 | The essential role of WD repeat domain 77 in prostate tumor initiation induced by Pten loss |
| Q47818549 | WNT signalling in prostate cancer. |
Search more.